Taiwan FDA registration 4ddfa9cc588e0e57e2f3ac6023a32703

Prokasa Biotech Morphine Test Reagent

TW: 璞笠生技嗎啡檢驗試劑

Taiwan·Risk Class 2·PULI BIOTECHNOLOGY CO., LTD.·Registered Aug 15, 2022 – Aug 15, 2027Active

Registration details

Analysis ID: 4ddfa9cc588e0e57e2f3ac6023a32703

Company information

Manufacturer: PULI BIOTECHNOLOGY CO., LTD.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: PULI BIOTECHNOLOGY CO., LTD.

Product details

Intended Use: The concentration of morphine (MOR) in human urine is qualitatively measured, and the threshold standard of this reagent for MOR is set to 300 ng/ml. Can be used by professionals and general staff.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.3640 嗎啡試驗系統
Import Information: 國產;; QMS/QSD

Dates and status

Registration Date: Aug 15, 2022
Expiry Date: Aug 15, 2027

About this record

Access comprehensive regulatory information for Prokasa Biotech Morphine Test Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4ddfa9cc588e0e57e2f3ac6023a32703 and manufactured by PULI BIOTECHNOLOGY CO., LTD.. The authorized representative in Taiwan is PULI BIOTECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.